BMC, along with Springer and Nature, has a leading portfolio of genetics and genomics journals, with particular emphasis on open access. Our comprehensive portfolio includes high profile selective journals such as Genome Biology, Genome Medicine, Nature Genetics and Human Genetics, as well as broad-scope journals such as BMC Genomics. 2020 is the 20th anniversary of The Human Genome Project, and also of BMC.
2020 has demonstrated the power of genomics to contribute to healthcare, especially to the genetic identification of the cause of COVID-19, and Springer Nature has prioritized the rapid publication of genetics in this area while maintaining our standards for peer review and encouraged the early sharing of relevant manuscripts through preprints. This was also the year when the Nobel Prize in Chemistry was awarded to Emmanuelle Charpentier and Jennifer Doudna for the development of a method for gene editing.
Next year, we look forward to the launch of BMC Genomic Data, building on our expertise in genetics and in data sharing, and a special issue on genomics and climate change in Genome Biology.